2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Colorectal Neoplasms
5948
Pancreatic Neoplasms
3563
Carcinoma, Hepatocellular
3273
Stomach Neoplasms
3057
Colonic Neoplasms
2328
Rectal Neoplasms
2192
Esophageal Neoplasms
1801
Liver Neoplasms
1247
Neoplasms
1181
Breast Neoplasms
1064
Neoplasm Metastasis
871
Carcinoma, Non-Small-Cell Lung
794
Lung Neoplasms
745
Cholangiocarcinoma
743
Gastrointestinal Neoplasms
662
Ovarian Neoplasms
630
Esophageal Squamous Cell Carcinoma
585
Prostatic Neoplasms
485
Melanoma
457
Biliary Tract Neoplasms
441
Head and Neck Neoplasms
376
Uterine Cervical Neoplasms
344
Carcinoma, Renal Cell
329
Gastrointestinal Stromal Tumors
326
Adenocarcinoma Of Esophagus
315
Sarcoma
304
Barrett Esophagus
300
Anus Neoplasms
284
Gallbladder Neoplasms
283
Endometrial Neoplasms
281
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suicidal Ideation
×
Gastrointestinal
×
Clear all
NCT03284879
2025-09-08
Post-Marketing Surveillance Study of OTEZLA
Amgen
Completed
1,086 enrolled